telmisartan has been researched along with Gastrointestinal Stromal Neoplasm in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chiyo, T; Fujihara, S; Fujimori, A; Fujita, K; Iwama, H; Kobara, H; Kobayashi, N; Masaki, T; Matsui, T; Mori, H; Morishita, A; Nishiyama, N; Nomura, T; Okano, K; Oura, K; Suzuki, Y; Tadokoro, T; Tani, J; Tingting, S; Yachida, T; Yoneyama, H | 1 |
1 other study(ies) available for telmisartan and Gastrointestinal Stromal Neoplasm
Article | Year |
---|---|
Antihypertensive drug telmisartan inhibits cell proliferation of gastrointestinal stromal tumor cells in vitro.
Topics: AMP-Activated Protein Kinases; Angiogenesis Inducing Agents; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Humans; MicroRNAs; Telmisartan; Tissue Array Analysis | 2020 |